PVLA

Palvella Therapeutics
PVLA

Overview Fund Trends Analyst Outlook Journalist POV

81 hedge funds and large institutions have $82.2M invested in Palvella Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

24% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 29

Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$55K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$690K
2
+$462K
3
+$372K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$330K
5
SFM
Sphera Funds Management
Israel
+$257K

Top Sellers

1
-$1.68M
2
-$1.35M
3
-$1.09M
4
Renaissance Technologies
Renaissance Technologies
New York
-$245K
5
Millennium Management
Millennium Management
New York
-$235K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$555K
27
$499K
28
$489K
29
$428K
30
$391K
31
$359K
32
$353K
33
$323K
34
$318K
35
$258K
36
$246K
37
$232K
38
$231K
39
$209K
40
$204K
41
$201K
42
$186K
43
$162K
44
$154K
45
$149K
46
$149K
47
$129K
48
$126K
49
$114K
50
$99K
1
2
3 4